# bib

id: cord-305234-nclk7bbo
author: Do, Mytrang H.
title: Strategies to prevent SARS-CoV-2 transmission during dermatologic head and neck surgery
date: 2020-06-27
extension: .txt
mime: text/plain
words: 147
sentence: 6
flesch: 42
cache: cache/cord-305234-nclk7bbo.txt
txt: txt/cord-305234-nclk7bbo.txt
summary:
  key: cord-305234-nclk7bbo authors: Do, Mytrang H.; Minkis, Kira; Petukhova, Tatyana A.; Lipner, Shari R. title: Strategies to prevent SARS-CoV-2 transmission during dermatologic head and neck surgery date: 2020-06-27 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.06.983 sha: doc_id: 305234 cord_uid: nclk7bbo nan . Furthermore, the patient's mouth and nose are often exposed We hope that these suggestions provide the best possible protection for dermatologic efficiency particle air, RT-PCR, reverse transcription-polymerase chain reaction, SARS-CoV-2, 81 severe acute respiratory syndrome coronavirus 2 Head and neck surgery is a high-risk procedure for COVID-19 87 transmission and there is a need for a preventive strategy to protect professionals Detection of SARS-CoV-2 in Different Types of Clinical 4.


id: cord-285691-pceenwb6
author: Falo, Louis D.
title: Advances in skin science enable the development of a COVID-19 Vaccine
date: 2020-05-30
extension: .txt
mime: text/plain
words: 181
sentence: 5
flesch: 12
cache: cache/cord-285691-pceenwb6.txt
txt: txt/cord-285691-pceenwb6.txt
summary:
  Taken together, these and studies by others demonstrate the potential for the development of cutaneous immune engineering strategies to control systemic immune responses including the potential for developing novel vaccine strategies and immunotherapies, and even negative immunization strategies to treat systemic allergy and autoimmune diseases. The immunological anatomy of the skin Antigen-Presenting cells in the skin Microneedles for drug and vaccine delivery Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development Improved cutaneous genetic immunization by microneedle array delivery of an adjuvanted adenovirus vaccine


id: cord-301478-j4b2534p
author: Gisondi, Paolo
date: 2020-04-21
extension: .txt
mime: text/plain
words: 274
sentence: 10
flesch: 31
cache: cache/cord-301478-j4b2534p.txt
txt: txt/cord-301478-j4b2534p.txt
title:
  Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment

summary:
  * asymptomatic individuals were not tested so the true number of COVID-19 positive patients is unknown; CNI: calcineurin inhibitors; mTORi mammalian target of rapamaycin; PsA: psoriatic arthritis; PsO: psoriasis Data of psoriasis and transplant patients are derived from electronic medical record of the Hospital. key: cord-301478-j4b2534p authors: Gisondi, Paolo; Zaza, Gianluigi; Del Giglio, Micol; Rossi, Mattia; Iacono, Valentina; Girolomoni, Giampiero title: Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment date: 2020-04-21 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.04.085 sha: doc_id: 301478 cord_uid: j4b2534p nan Manuscript words: 493 13 We performed a retrospective observational study in order to determine whether Hospital and compared to the Verona population (n=257,353) ( Table 1 ).


id: cord-276147-30buoweg
author: Avancini, Joao
title: Absence of specific cutaneous manifestations of SARS-Cov-2 in a reference center in Brazil
date: 2020-09-15
extension: .txt
mime: text/plain
words: 278
sentence: 8
flesch: 37
cache: cache/cord-276147-30buoweg.txt
txt: txt/cord-276147-30buoweg.txt
summary:
  To the editor: We read with interest the letters from the New York City report regarding the absence of COVID toes lesions on their patients and the recommendation of caution when concluding that cutaneous findings are specifically due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). key: cord-276147-30buoweg authors: Avancini, Joao; Miyamoto, Denise; Arnone, Marcelo; Villas-Boas Gabbi, Tatiana; Ferreira, Paula Silva; Neta, Cyro Festa; Sanches, Jose Antonio title: Absence of specific cutaneous manifestations of SARS-Cov-2 in a reference center in Brazil date: 2020-09-15 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.09.030 sha: doc_id: 276147 cord_uid: 30buoweg nan Contents of the manuscript have not been previously published and are not currently submitted elsewhere.


id: cord-262311-vdbk50pl
author: Grant-Kels, Jane M.
title: Response to “Risks of Hydroxychloroquine use for COVID-19 prophylaxis”
date: 2020-04-26
extension: .txt
mime: text/plain
words: 318
sentence: 8
flesch: 23
cache: cache/cord-262311-vdbk50pl.txt
txt: txt/cord-262311-vdbk50pl.txt
summary:
  These findings cast doubt on the effectiveness of HCZ prophylaxis. Risks of Hydroxychloroquine use for COVID-19 prophylaxis Does Hydroxychloroquine Combat COVID-19? A Timeline of Evidence Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: an observational study Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial Bell CL Hydroxychloroquine in the treatment of rheumatoid arthritis Hydroxychloroquine and Other Autoimmune Drugs Don't Fully Protect Against Coronavirus, Early Data Suggest


id: cord-011451-nnunjora
author: Kolitz, Elysha
date: 2020-05-19
extension: .txt
mime: text/plain
words: 292
sentence: 10
flesch: 47
cache: cache/cord-011451-nnunjora.txt
txt: txt/cord-011451-nnunjora.txt
title:
  “Considerable unreimbursed medical care is delivered through electronic patient portals: a retrospective review”

summary:
  key: cord-011451-nnunjora authors: Kolitz, Elysha; Smith, Austin; Taylor, Oliver; Mauskar, Melissa M.; Goff, Heather title: “Considerable unreimbursed medical care is delivered through electronic patient portals: a retrospective review” date: 2020-05-19 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.05.054 sha: doc_id: 11451 cord_uid: nnunjora nan We conducted a retrospective review to assess patient-initiated messages on the online portal 37 used in the dermatology clinic at UT Southwestern Medical Center called MyChart. and medical history questionnaires. The message type was verified, and medical advice requests 50 were reviewed independently by each author.


id: cord-263664-isgcm4lj
author: Lee, Justin
title: Male Balding is a Major Risk Factor for Severe COVID-19.
date: 2020-07-22
extension: .txt
mime: text/plain
words: 341
sentence: 15
flesch: 46
cache: cache/cord-263664-isgcm4lj.txt
txt: txt/cord-263664-isgcm4lj.txt
summary:
  Descriptive frequencies for COVID-19 results, balding patterns, age, and BMI are reported in Our study compared a large sample of hospitalized COVID-19 positive patients to a control group of hospitalized COVID-19 negative patients and thus builds upon and supports the observations of Wambier 1 and coauthors. Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients -the Gabrin sign A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain -A potential clue to the role of androgens in COVID-19 severity Male pattern baldness: classification and incidence Resource 100423 Screenshot from touchscreen questionnaire used to capture field 2395.


id: cord-261929-x688qqdr
author: Geskin, Larisa J.
title: Perspectives on the Recommendations for Skin Cancer Management During the COVID-19 Pandemic
date: 2020-05-06
extension: .txt
mime: text/plain
words: 240
sentence: 7
flesch: 37
cache: cache/cord-261929-x688qqdr.txt
txt: txt/cord-261929-x688qqdr.txt
summary:
  key: cord-261929-x688qqdr authors: Geskin, Larisa J.; Trager, Megan H.; Aasi, Sumaira Z.; Bickers, David R.; Carvajal, Richard D.; Nghiem, Paul; Taback, Bret; Zeitouni, Nathalie C.; Samie, Faramarz H. title: Perspectives on the Recommendations for Skin Cancer Management During the COVID-19 Pandemic date: 2020-05-06 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.05.002 sha: doc_id: 261929 cord_uid: x688qqdr nan Therapy-related travel for the high-risk category (high-risk cSCC, invasive, thick and 56 ulcerated melanoma, MCC, tumors with aggressive histology or in sensitive areas) must be 57 weighed against each patient's risks. For rapidly growing cSCC, particularly of the head and 58 neck (eyes, ears, lips, mouth) and symptomatic lesions, more immediate treatment may be 59 considered.


id: cord-318033-vlwlgp82
author: Su, Mack Y.
title: Expansion of asynchronous teledermatology during the COVID-19 pandemic
date: 2020-08-18
extension: .txt
mime: text/plain
words: 338
sentence: 13
flesch: 26
cache: cache/cord-318033-vlwlgp82.txt
txt: txt/cord-318033-vlwlgp82.txt
summary:
  Asynchronous teledermatology visits also increased, driven primarily by eVisits. key: cord-318033-vlwlgp82 authors: Su, Mack Y.; Das, Shinjita title: Expansion of asynchronous teledermatology during the COVID-19 pandemic date: 2020-08-18 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.08.054 sha: doc_id: 318033 cord_uid: vlwlgp82 nan person visits at our institution in April 2020 (n=67) represented less than 1% of the volume in April 2019 (n=7919; Table 1 ).


id: cord-274696-h7kihj9w
author: Piccolo, Vincenzo
date: 2020-05-22
extension: .txt
mime: text/plain
words: 349
sentence: 14
flesch: 44
cache: cache/cord-274696-h7kihj9w.txt
txt: txt/cord-274696-h7kihj9w.txt
title:
  Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions

summary:
  Although the comparison between acral lesions in asymptomatic patients and ischemic lesions in severe cases is important, we find the term acute acro-ischemic lesions not accurate. As the authors state, true ischemic lesions have been reported in severely-ill patients with proven coronavirus infection 3 .


id: cord-252521-m7asfqva
author: Shah, Monica
title: Hidradenitis suppurativa: the importance of virtual outpatient care during COVID-19 pandemic
date: 2020-05-01
extension: .txt
mime: text/plain
words: 400
sentence: 13
flesch: 39
cache: cache/cord-252521-m7asfqva.txt
txt: txt/cord-252521-m7asfqva.txt
summary:
  Virtual visits also allow us to counsel patients 68 regarding maintenance regimens for the prevention of disease flares, HS action plans informing steps to 69 take during HS exacerbations and when to contact a provider, and methods to improve overall mental 70 health, including maintaining a healthy diet, utilizing warm compresses and engaging in support groups 71 through the CSPA. We caution 58 against interruption in care for HS patients due to the potential for increased severity and/or frequency of 59 suicidal behaviours, depression and anxiety, especially considering the additive stress and anxiety 60 resulting from the current socially-isolating quarantine climate.


id: cord-304330-egvdvvtx
author: Damsky, William
date: 2020-06-19
extension: .txt
mime: text/plain
words: 443
sentence: 10
flesch: 25
cache: cache/cord-304330-egvdvvtx.txt
txt: txt/cord-304330-egvdvvtx.txt
title:
  When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection

summary:
  Characterization of 87 acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 88 patients during the COVID-19 outbreak Chilblains in children in 91 the setting of COVID 19 pandemic COVID-19) infection-94 induced chilblains: A case report with histopathologic findings Classification of the 97 cutaneous manifestations of COVID 19: a rapid prospective nationwide 98 consensus study in Spain with 375 cases Pernio-like skin lesions associated 101 with COVID-19: a case series of 318 patients from 8 countries Type I IFN immunoprofiling in 104 COVID-19 patients Imbalanced Host Response to Together, these data suggest that COVID toes may be a 46 marker of patients that are able to mount a robust anti-viral immune response to SARS-CoV-2 and prognosticate a milder course of COVID-19.


id: cord-336450-2ndan331
author: Shaw, Katharina S.
date: 2020-08-07
extension: .txt
mime: text/plain
words: 426
sentence: 11
flesch: 31
cache: cache/cord-336450-2ndan331.txt
txt: txt/cord-336450-2ndan331.txt
title:
  Response to “Patient preference for cellulitis treatment: at-home care is preferred to hospital-based treatment”

summary:
  Moreover, given that patients may be reluctant to seek hospital-74 based care, we highlight the need to remain accessible to patients in the outpatient setting or 75 through virtual visits, particularly during periods of stress on local hospital systems. key: cord-336450-2ndan331 authors: Shaw, Katharina S.; Karagounis, Theodora K.; Yin, Lu; Gibbon, Grace; Betensky, Rebecca A.; Lo Sicco, Kristen I.; Femia, Alisa N. title: Response to “Patient preference for cellulitis treatment: at-home care is preferred to hospital-based treatment” date: 2020-08-07 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.07.120 sha: doc_id: 336450 cord_uid: 2ndan331 nan preference of patients for at-home treatment of cellulitis rather than hospital-based care.


id: cord-274750-fynxciwg
author: Peterson, Danielle
title: Calm before the storm: understanding the role of JAK inhibitors in COVID-19
date: 2020-04-25
extension: .txt
mime: text/plain
words: 467
sentence: 19
flesch: 39
cache: cache/cord-274750-fynxciwg.txt
txt: txt/cord-274750-fynxciwg.txt
summary:
  Important to note is that the 64 theoretical benefit of JAK inhibitors in this setting is not limited to upadacitinib and baricitinib but also 65 applies to other JAK inhibitors including ruxolitinib and tofacitinib. We strongly agree that there may be a 56 role for JAK inhibitors in treating SARS-CoV-2-associated CRS.


id: cord-273493-xsroivzj
author: Manalo, Iviensan F.
title: A Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis
date: 2020-04-10
extension: .txt
mime: text/plain
words: 472
sentence: 23
flesch: 45
cache: cache/cord-273493-xsroivzj.txt
txt: txt/cord-273493-xsroivzj.txt
summary:
  Ten days after testing positive, and with complete clinical convalescence of COVID-19 symptoms, she was sitting outside in long pants under direct sunlight for approximately 20-30 minutes. Cutaneous manifestations in COVID-19: a first perspective Livedo reticularis: an update Acute pulmonary embolism and COVID-19 pneumonia: a random association?


id: cord-304874-pjdedw7w
author: Grant-Kels, Jane M.
title: Invited response to the comment on “Dermatology Residents and the Care of COVID-19 Patients”
date: 2020-04-21
extension: .txt
mime: text/plain
words: 509
sentence: 26
flesch: 62
cache: cache/cord-304874-pjdedw7w.txt
txt: txt/cord-304874-pjdedw7w.txt
summary:
  3. I am very sensitive to the fact that many residents are young with spouses and children. As someone who is intimately involved with dermatology residents at two universities, I am personally very aware of residency concern and fear over this pandemic.


id: cord-309914-1lpl26eo
author: Peterson, Danielle
title: The use of Janus kinase inhibitors in the time of SARS-CoV-2
date: 2020-04-09
extension: .txt
mime: text/plain
words: 503
sentence: 18
flesch: 45
cache: cache/cord-309914-1lpl26eo.txt
txt: txt/cord-309914-1lpl26eo.txt
summary:
  46 We analyzed and collated Adverse Events data from JAKi clinical trials. In light of the 42 growing off-label use of JAKi in dermatology in addition to pharmaceutical industry sponsored clinical 43 trials of JAKi for alopecia areata, atopic dermatitis, vitiligo, etc, dermatologists need data to better 44 understand the risks of JAKi treatment in order to best manage and counsel our patients during this 45 unique time.


id: cord-256565-59bnifxm
author: Lebwohl, Mark
date: 2020-04-10
extension: .txt
mime: text/plain
words: 502
sentence: 20
flesch: 38
cache: cache/cord-256565-59bnifxm.txt
txt: txt/cord-256565-59bnifxm.txt
title:
  Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”

summary:
  key: cord-256565-59bnifxm authors: Lebwohl, Mark; Rivera-Oyola, Ryan; Murrell, Dedee F. title: Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution” date: 2020-04-10 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.03.103 sha: doc_id: 256565 cord_uid: 59bnifxm nan Reply to: ''COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution'' To the Editor: We thank Dr Kansal 1 from the All India Institute of Medical Sciences for her pertinent comments in response to our publication on the use of biologic agents for psoriasis patients in the current COVID-19 pandemic. Finally, we know that dupilumab, in addition to treating atopic dermatitis, which in itself can be debilitating, also treats asthma, which could be a complicating factor in COVID-19 infection.


id: cord-282355-urys21ry
author: Ortega-Quijano, Daniel
date: 2020-05-04
extension: .txt
mime: text/plain
words: 556
sentence: 20
flesch: 42
cache: cache/cord-282355-urys21ry.txt
txt: txt/cord-282355-urys21ry.txt
title:
  Reply to “Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients”: discussing specificity

summary:
  This type of study would calculate the association of COVID-19 status (yes/no) with the type of exanthem (varicella-like/non varicella-like) in a predetermined number of patients (to ensure sufficient statistical power) and in a defined population with a known prevalence of COVID-19 disease. This gives varicella-like rash additional COVID-19 positive predictive value compared to the rest of the rashes.


id: cord-034195-yiv8rp7y
author: Guhan, Samantha M.
date: 2020-10-23
extension: .txt
mime: text/plain
words: 546
sentence: 20
flesch: 41
cache: cache/cord-034195-yiv8rp7y.txt
txt: txt/cord-034195-yiv8rp7y.txt
title:
  COVID-19 and healthcare disparities: Innovative ways to meet the dermatologic needs of patients experiencing homelessness

summary:
  We hypothesized that dermatologists can further aid this population by mobilizing 57 critical supplies commonly found in our offices and using the generosity of local companies to 58 create COVID-19 care kits, which contain items necessary to protect PEH from disease. The final kits contained soap, hand sanitizer, moisturizer, 67 The 2019 Annual 89 Homeless Assessment Report (AHAR) to Congress Assessment of 92 SARS-CoV-2 Infection Prevalence in Homeless Shelters -Four COVID-19 and Racial Disparities dental care products, puzzles, headphones, a COVID-19 informational pamphlet, and other 68 personal hygiene items ( Figure 1 ).


id: cord-294262-yvbufnf4
author: Fernandez-Nieto, D.
date: 2020-06-22
extension: .txt
mime: text/plain
words: 541
sentence: 23
flesch: 49
cache: cache/cord-294262-yvbufnf4.txt
txt: txt/cord-294262-yvbufnf4.txt
title:
  Comment on: “To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out. Characterization of herpetic lesions in hospitalized COVID-19 patients.”

summary:
  48 We agree with the authors that there is a potential role for herpetic viral infections and 49 super-infections in COVID-19 patients. In our current experience, the diagnosis of 55 herpesvirus infection in COVID-19 patients does not usually involve diagnostic doubts, 56 due to the clinical presentation and reported symptoms being typical of the disease, 57 even when lesions are extensive (Figure 1) .


id: cord-267357-7aap2cte
author: Elston, Dirk M.
title: The coronavirus (COVID-19) epidemic and patient safety
date: 2020-02-16
extension: .txt
mime: text/plain
words: 605
sentence: 22
flesch: 30
cache: cache/cord-267357-7aap2cte.txt
txt: txt/cord-267357-7aap2cte.txt
summary:
  key: cord-267357-7aap2cte authors: Elston, Dirk M. title: The coronavirus (COVID-19) epidemic and patient safety date: 2020-02-16 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.02.031 sha: doc_id: 267357 cord_uid: 7aap2cte nan The coronavirus (COVID-19) epidemic and patient safety Dirk M. Elston, MD Charleston, South Carolina I n this issue of the JAAD, Chen et al 1 discuss patient safety measures in a Chinese dermatology clinic during the coronavirus outbreak (2019-nCoV acute respiratory disease), including patient screening, respiratory precautions, and telemedicine consultations. Substandard infection control, including errors in equipment sterilization and standard precautions, contributed to the outbreak. Prevention of transmission of blood-borne infections deserves special mention, and readers should review the JAAD continuing medical education articles that focused on patient safety and blood-borne pathogens (https://www.jaad. org/article/S0190-9622(09)00603-3/fulltext and https://www.jaad.org/article/S0190-9622(09)00602-1/fulltext).


id: cord-350317-a9qd3xdr
author: Xu, Qiannan
title: If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19
date: 2020-11-05
extension: .txt
mime: text/plain
words: 701
sentence: 25
flesch: 44
cache: cache/cord-350317-a9qd3xdr.txt
txt: txt/cord-350317-a9qd3xdr.txt
summary:
  After IL-17 antibody treatment, the skin ACE2 expression was downregulated which meant IL-17 antibody could lower the risk of COVID-19 through lessening the cells which could interact with SARS-CoV-2. To evaluate the influence of IL-17 antibody on skin ACE2 expression, we randomly selected five psoriasis patients who were treated with IL-17 antibody (Taltz, Eli Lilly and Company).


id: cord-278754-vy5c7411
author: McGee, Jean S.
title: Fighting COVID-19: Early Teledermatology Lessons Learned
date: 2020-06-15
extension: .txt
mime: text/plain
words: 568
sentence: 27
flesch: 42
cache: cache/cord-278754-vy5c7411.txt
txt: txt/cord-278754-vy5c7411.txt
summary:
  In contrast, 60% of teledermatology visits for evaluation of lesion(s) lead to a recommendation to follow up in person for re-evaluation and/or biopsy. Lastly, 75% of teledermatology visits with durations of 20 minutes or greater were conducted via telephone, rather than a video-based platform.


id: cord-294871-bqw48zi5
author: Wambier, Carlos Gustavo
date: 2020-07-29
extension: .txt
mime: text/plain
words: 641
sentence: 21
flesch: 40
cache: cache/cord-294871-bqw48zi5.txt
txt: txt/cord-294871-bqw48zi5.txt
title:
  Androgenetic alopecia in COVID-19: compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign

summary:
  5 It is remarkable that severe outcomes 81 such as requirement for ventilator and/or fatalities have occurred in men with this phenotype 82 without other known co-morbidities at younger age groups, such as 35-45 years. Finally, severe AGA, 78 (HNS=3-7) -the Gabrin Sign -is an objective phenotype, which reflects the individual androgen 79 sensitivity throughout decades of life.


id: cord-347293-fp8phk0p
author: Kearns, Donovan G.
title: Assessing The Risk of Adalimumab Use For Hidradenitis Suppurativa During The COVID-19 Pandemic
date: 2020-07-28
extension: .txt
mime: text/plain
words: 614
sentence: 23
flesch: 42
cache: cache/cord-347293-fp8phk0p.txt
txt: txt/cord-347293-fp8phk0p.txt
summary:
  With limited real-life data from COVID-19 infection in patients with hidradenitis suppurativa (HS) receiving adalimumab, we can use previous drug trials to extrapolate the potential risk to patients, based upon the change in infection rate when compared to placebo. Adalimumab, a tumor necrosis factor alpha (TNF-α) antagonist, is the only FDA approved biologic treatment for patients >12 years with for moderate to severe HS. This is consistent with a recent case series documenting mild, uncomplicated disease in a small cohort of HS patients receiving adalimumab.


id: cord-323241-1twnqr4k
author: Patrì, Angela
date: 2020-04-09
extension: .txt
mime: text/plain
words: 636
sentence: 27
flesch: 41
cache: cache/cord-323241-1twnqr4k.txt
txt: txt/cord-323241-1twnqr4k.txt
title:
  Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?

summary:
  key: cord-323241-1twnqr4k authors: Patrì, Angela; Gallo, Lucia; Guarino, Maria; Fabbrocini, Gabriella title: Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection? date: 2020-04-09 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.03.098 sha: doc_id: 323241 cord_uid: 1twnqr4k nan To the Editor: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for the coronavirus disease (COVID-19), first identified in Wuhan, China, in December 2019, and that has now actually spread worldwide. The human-tohuman transmission routes hitherto recognized include direct transmission, through cough, sneeze, droplet inhalation, and contact transmission, comprising contact with oral, nasal, and eye mucous membranes.


id: cord-353247-swex393r
author: Brumfiel, Caitlin M.
title: A national webinar for dermatology applicants during the COVID-19 pandemic
date: 2020-09-17
extension: .txt
mime: text/plain
words: 835
sentence: 44
flesch: 41
cache: cache/cord-353247-swex393r.txt
txt: txt/cord-353247-swex393r.txt
summary:
  2020 Advice for the Ophthalmology Residency Match Season The Shifting Landscape of the 2020-21 Dermatology Application Cycle in the Era of the 96 • Students submit no more than 60 applications to dermatology programs (recommended 40-60) • Students accept no more than 15 interviews (recommended 12-15) • Programs do not offer in-person away rotations, except for students without home dermatology residency programs • Programs conduct virtual interviews for all applicants 110 How should students express interest in specific programs given most dermatology away rotations are cancelled? Underrepresented minorities 76 and students without home dermatology programs constituted a significant portion of the 77 webinar audience, demonstrating the need and opportunity to fill gaps in recruitment and 78 mentorship for these groups.


id: cord-305119-y3a1qyi9
author: Price, Kyla N.
title: COVID-19 and immunomodulator/immunosuppressant use in dermatology
date: 2020-03-26
extension: .txt
mime: text/plain
words: 819
sentence: 42
flesch: 32
cache: cache/cord-305119-y3a1qyi9.txt
txt: txt/cord-305119-y3a1qyi9.txt
summary:
  [2] [3] [4] Interleukin (IL) 17 cytokines are important for immune cell recruitment to infection sites to promote clearance, while also activating downstream cascades of cytokines and chemokines. Immunosuppressants decrease cytokines that recruit and differentiate immune cells needed to clear the infection.


id: cord-309230-4f5frlr5
author: Yu, Jiade
date: 2020-10-01
extension: .txt
mime: text/plain
words: 988
sentence: 41
flesch: 38
cache: cache/cord-309230-4f5frlr5.txt
txt: txt/cord-309230-4f5frlr5.txt
title:
  Occupational Dermatitis to Facial Personal Protective Equipment in Healthcare Workers: A Systematic Review

summary:
  76 Two studies on HCWs not in epidemics or pandemics described facial contact dermatitis 6 and 77 facial skin concerns, some of which may have been related to masks. Allergic contact dermatitis was reported to the elastic straps, glue, and formaldehyde released from the mask fabric.


id: cord-338597-aq80vius
author: Baniandrés-Rodríguez, O.
date: 2020-10-26
extension: .txt
mime: text/plain
words: 1963
sentence: 74
flesch: 44
cache: cache/cord-338597-aq80vius.txt
txt: txt/cord-338597-aq80vius.txt
title:
  Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis

summary:
  key: cord-338597-aq80vius authors: Baniandrés-Rodríguez, O.; Vilar-Alejo, J.; Rivera, R.; Carrascosa, J. M.; Daudén, E.; Herrera-Acosta, E.; Sahuquillo-Torralba, A.; Gómez-García, F. J.; Nieto-Benito, L. M.; de la Cueva, P.; López-Estebaranz, J. L.; Belinchón, I.; Ferrán, M.; Alsina, M.; Rodriguez, L.; Carretero, G.; García-Donoso, C.; Ballescá, F.; Llamas-Velasco, M.; Herrera-Ceballos, E.; Botella-Estrada, R.; Ruiz-Genao, D. P.; Riera-Monroig, J.; Descalzo, M. A.; García-Doval, I. title: Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis date: 2020-10-26 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.10.046 sha: doc_id: 338597 cord_uid: aq80vius nan The BIOBADADERM project is promoted by the Fundación Piel Sana Academia Española de Dermatología y Venereología, which receives financial support from the Spanish Medicines and Health Products Agency (Agencia Española de Medicamentos y Productos Sanitarios) and from pharmaceutical companies (Abbott/Abbvie, Almirall, Janssen, Leo Pharma, Lilly, Novartis and UCB). The use of systemic treatments in psoriatic patients during the pandemic has been the subject of extensive debate.


id: cord-286132-ag2l1xa7
author: Akiyama, Shintaro
date: 2020-08-11
extension: .txt
mime: text/plain
words: 3135
sentence: 88
flesch: 34
cache: cache/cord-286132-ag2l1xa7.txt
txt: txt/cord-286132-ag2l1xa7.txt
title:
  The risk of respiratory tract infections and interstitial lung disease with IL-12/23 and IL-23 antagonists in patients with autoimmune diseases: a systematic review and meta-analysis

summary:
  Use and avoidance of continuity corrections in meta-analysis of sparse data an anti-interleukin-23 monoclonal antibody, for the treatment of moderate to severe plaque-type psoriasis in Japanese patients: Efficacy and safety results from a phase 3, randomized, double-blind, placebo-controlled study Safety and efficacy of guselkumab in Japanese patients with moderate-to-severe plaque psoriasis: a randomized, placebo-controlled, ascending-dose study Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo-and active comparator-controlled VOYAGE 1 trial Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis Efficacy and Safety of Guselkumab, an Anti-interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis: A Randomized Clinical Trial First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial Pharmacokinetics of Tildrakizumab (MK-3222), an Anti-IL-23 Monoclonal After Intravenous or Subcutaneous Administration in Healthy Subjects Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis Safety and efficacy of ABT-874 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial Anti-interleukin-12 antibody for active Crohn's disease A phase 2, 24-week, randomized, placebo-controlled, double-blind study examining the efficacy and safety of an anti-interleukin-12 and -23 monoclonal antibody in patients with relapsing-remitting or secondary progressive multiple sclerosis Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: results from a phase 3 clinical trial (LOTUS) Efficacy and safety of ustekinumab for the treatment of moderate-to-severe psoriasis: a phase III, randomized, placebo-controlled trial in Taiwanese and Korean patients (PEARL) Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) Methods We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs).


id: cord-346287-xg176mi7
author: Wan, Marilyn T.
title: In response to: “Reply to Research Letter.”
date: 2020-07-29
extension: .txt
mime: text/plain
words: 453
sentence: 14
flesch: 39
cache: cache/cord-346287-xg176mi7.txt
txt: txt/cord-346287-xg176mi7.txt
summary:
  23 Reply to Research Letter The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A metaestimate of pivotal trials relevant to decision-making during the COVID-19 pandemic Characteristics of drugs safety signals that predict safety related product information update The Risk of Respiratory Tract Infections in Psoriasis Patients Treated With IL-23-pathway Inhibiting Biologics: A Meta-Estimate of Pivotal Trials Relevant to Decision-Making During the COVID-19 Pandemic In the IL-23 analysis, we also noted that the confidence intervals overlap, and 19 therefore, we cannot conclude with certainty that there is a true difference in RTI risk between 20 biologics that target IL-17 versus IL-23.


id: cord-316793-clshw9v2
author: Sethy, Mitanjali
title: Cling film for mobile phone to prevent cross-infection during COVID-19 pandemic
date: 2020-07-02
extension: .txt
mime: text/plain
words: 194
sentence: 7
flesch: 50
cache: cache/cord-316793-clshw9v2.txt
txt: txt/cord-316793-clshw9v2.txt
summary:
  key: cord-316793-clshw9v2 authors: Sethy, Mitanjali; Krishna, Vamshi; Srinivas, Chakravarthi R. title: Cling film for mobile phone to prevent cross-infection during COVID-19 pandemic date: 2020-07-02 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.06.1008 sha: doc_id: 316793 cord_uid: clshw9v2 nan Mobile phone has become an inseparable part of dermatology practice and dermatologists use mobile phones in various ways while clinically examining the patients. However, it's practically not feasible to sanitize mobile phones with alcohol-containing sanitizer or chlorine solutions as there may be an ill effect of these chemical solutions on the mobile screen.


id: cord-285030-ecsa83kf
author: Jimenez-Cauhe, Juan
date: 2020-04-10
extension: .txt
mime: text/plain
words: 133
sentence: 3
flesch: 39
cache: cache/cord-285030-ecsa83kf.txt
txt: txt/cord-285030-ecsa83kf.txt
title:
  Reply to “COVID-19 can present with a rash and be mistaken for Dengue”: Petechial rash in a patient with COVID-19 infection

summary:
  key: cord-285030-ecsa83kf authors: Jimenez-Cauhe, Juan; Ortega-Quijano, Daniel; Prieto-Barrios, Marta; Moreno-Arrones, Oscar M.; Fernandez-Nieto, Diego title: Reply to “COVID-19 can present with a rash and be mistaken for Dengue”: Petechial rash in a patient with COVID-19 infection date: 2020-04-10 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.04.016 sha: doc_id: 285030 cord_uid: ecsa83kf nan Dermatologists have a unique opportunity to study COVID-19 cutaneous manifestations during this pandemic, and illustrative images are the first step for other colleagues to start looking for them. COVID-19 can present with a rash and be mistaken for Dengue Cutaneous manifestations in COVID-19: a first perspective


id: cord-296013-6ej3pd0u
author: Trinidad, John
title: Telemedicine for Inpatient Dermatology Consultations in Response to the COVID-19 Pandemic
date: 2020-04-24
extension: .txt
mime: text/plain
words: 328
sentence: 9
flesch: 16
cache: cache/cord-296013-6ej3pd0u.txt
txt: txt/cord-296013-6ej3pd0u.txt
summary:
  5 Dermatologists are poised to 58 utilize teledermatology to increase access to dermatologic care for hospitalized patients, reduce 59 the risk of infection of patients, trainees and staff, and reduce the use of precious resources such 60 as personal protective equipment (PPE) and medical supplies. Outpatient 55 teledermatology services have the potential to increase access to dermatology care, and to 56 address health care disparities for urban-underserved and rural populations.


id: cord-344361-amhc0ryh
author: Ruggiero, Giuseppe
date: 2020-06-01
extension: .txt
mime: text/plain
words: 578
sentence: 30
flesch: 51
cache: cache/cord-344361-amhc0ryh.txt
txt: txt/cord-344361-amhc0ryh.txt
title:
  Reply to: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak”

summary:
  key: cord-344361-amhc0ryh authors: Ruggiero, Giuseppe; Arcangeli, Fabio; Lotti, Torello; Ametrano, Orsola; Ruggiero, Cosimo; Cucchiara, Salvatore; Oliva, Salvatore title: Reply to: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak” date: 2020-06-01 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.05.122 sha: doc_id: 344361 cord_uid: amhc0ryh nan We read with interest Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak [1] . Pediatric Gastroenterology and Liver Unit, Maternal and Child Health Department Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak Epidemiological characteristics of 2143pediatric patients with 2019 coronavirus disease in China Delayed access or provision of care in Italy resulting from fear of COVID-19


id: cord-308212-l8flyso7
author: Kong, Ha Eun
date: 2020-04-21
extension: .txt
mime: text/plain
words: 566
sentence: 22
flesch: 38
cache: cache/cord-308212-l8flyso7.txt
txt: txt/cord-308212-l8flyso7.txt
title:
  Applying the ethical principles of resource allocation to drugs in limited supply during a public health crisis

summary:
  While the benefit of antimalarials to COVID-19 patients remains 61 uncertain, high-quality evidence supports continuing treatment in patients with severe SLE. Random selection can be used for selecting among patients with comparable prognoses.


id: cord-295371-ccqne6nu
author: Stoj, Victoria J.
title: Dermatology residents and the care of patients with coronavirus disease 2019 (COVID-19)
date: 2020-04-04
extension: .txt
mime: text/plain
words: 611
sentence: 28
flesch: 53
cache: cache/cord-295371-ccqne6nu.txt
txt: txt/cord-295371-ccqne6nu.txt
summary:
  Health care workers in Italy make up approximately 9% of confirmed COVID-19 cases in that country as of March 10, 2020. The bottom line is that to fulfill your obligation as a professional in the house of medicine, ensure medical care is delivered to those in need (distributive justice), help patients, and do no harm (beneficence and nonmaleficence,) and for your own dignity, do not call a lawyer!


id: cord-274517-9lewc581
author: Litchman, Graham H.
title: The Immediate Impact of COVID-19 on US Dermatology Practices
date: 2020-05-16
extension: .txt
mime: text/plain
words: 669
sentence: 30
flesch: 51
cache: cache/cord-274517-9lewc581.txt
txt: txt/cord-274517-9lewc581.txt
summary:
  The purpose of this study was to determine the magnitude of 33 the initial impact of COVID-19 on US dermatology outpatient care. 65 Our findings demonstrate the significant early impact of COVID-19 on US dermatologic care and can help 66 better understand national trends.


id: cord-325992-qik2w1f1
author: Torres, Angeli Eloise
title: Notes and Comments on “Proposed Approach for Re-using Surgical Masks in COVID-19 Pandemic”
date: 2020-05-21
extension: .txt
mime: text/plain
words: 273
sentence: 10
flesch: 28
cache: cache/cord-325992-qik2w1f1.txt
txt: txt/cord-325992-qik2w1f1.txt
summary:
  3 31 The authors' statement pertaining to UVC having less penetration and being less Proposed approach for reusing surgical masks in COVID-19 51 pandemic Other Methods of Decontamination of Filtering Facepiece N-95 Respirators during the COVID-54 The importance of form 56 fit testing in decontamination of N95 respirators: a cautionary note Ultraviolet 59 germicidal irradiation: possible method for respirator disinfection to facilitate reuse during 60 COVID-19 pandemic Efficacy of an Automated Multiple Emitter Whole-62 Room Ultraviolet-C Disinfection System Against Coronaviruses MHV and MERS-CoV Ultraviolet 65 germicidal irradiation of influenza-contaminated N95 filtering facepiece respirators For N95 respirators, failure of fit-testing after 30 decontamination would have potential catastrophic effects on healthcare providers.


id: cord-354902-t9df8vhc
author: Kearns, Donovan G.
title: Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic
date: 2020-06-10
extension: .txt
mime: text/plain
words: 592
sentence: 20
flesch: 37
cache: cache/cord-354902-t9df8vhc.txt
txt: txt/cord-354902-t9df8vhc.txt
summary:
  key: cord-354902-t9df8vhc authors: Kearns, Donovan G.; Uppal, Shelley; Chat, Vipawee S.; Wu, Jashin J. title: Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic date: 2020-06-10 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.06.015 sha: doc_id: 354902 cord_uid: t9df8vhc nan In the midst of the COVID-19 pandemic, physicians are using what's known of the SARS-CoV-2 2 virus to establish practice guidelines for dermatologic conditions, particularly in regard to the 3 use of immunosuppressive medications. Given that IL-13 4 and IL-13 are significant in orchestrating and maintaining adaptive immunity, we sought to 14 identify and address the risks associated with dupilumab use during the COVID-19 pandemic.


id: cord-302993-t4quwfva
author: Loh, Tiffany Y.
title: COVID-19 and its impact on medical student education in dermatology
date: 2020-05-12
extension: .txt
mime: text/plain
words: 460
sentence: 17
flesch: 26
cache: cache/cord-302993-t4quwfva.txt
txt: txt/cord-302993-t4quwfva.txt
summary:
  key: cord-302993-t4quwfva authors: Loh, Tiffany Y.; Hsiao, Jennifer L.; Shi, Vivian Y. title: COVID-19 and its impact on medical student education in dermatology date: 2020-05-12 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.05.026 sha: doc_id: 302993 cord_uid: t4quwfva nan Dermatology is a visual field, and repetitive patient encounters are required in order for 65 clinicians to develop the skills necessary for diagnosing and managing dermatologic conditions. 66 Teledermatology offers a potential solution to medical student education during the COVID-19 67 pandemic.


id: cord-266589-oj76ol8v
author: Wan, Marilyn T.
date: 2020-05-19
extension: .txt
mime: text/plain
words: 820
sentence: 33
flesch: 40
cache: cache/cord-266589-oj76ol8v.txt
txt: txt/cord-266589-oj76ol8v.txt
title:
  The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologics: A meta-estimate of pivotal trials relevant to decision-making during the COVID-19 pandemic

summary:
  Current understanding of viral immunology suggests that IL-17 is 10 not a dominant cytokine in viral immunity; however, IL-17 is important to mucosal immunity, 11 raising the hypothesis that biologics targeting IL-17 could potentially increase RTI risk. Meta-estimate of respiratory tract infections (includes upper respiratory tract infections, nasopharyngitis, rhinorrhea, influenza, oropharyngitis, pharyngitis, pharyngolaryngeal pain) from prescribing information adverse events tables.


id: cord-332859-j10n38ah
author: Muzumdar, Sonal
title: Dear Dermatoethicist: Medical Student Dermatology Rotations in the Context of COVID-19
date: 2020-06-24
extension: .txt
mime: text/plain
words: 575
sentence: 27
flesch: 33
cache: cache/cord-332859-j10n38ah.txt
txt: txt/cord-332859-j10n38ah.txt
summary:
  Beneficence is at play as rotating through dermatology benefits medical students as it is an excellent way for students to learn more about the field and help them determine if dermatology is in fact the specialty they would like to pursue. key: cord-332859-j10n38ah authors: Muzumdar, Sonal; Grant-Kels, Jane M.; Feng, Hao title: Dear Dermatoethicist: Medical Student Dermatology Rotations in the Context of COVID-19 date: 2020-06-24 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.06.070 sha: doc_id: 332859 cord_uid: j10n38ah nan We frequently have medical students rotate through our department but, due to the COVID-19 pandemic, we are hesitant to accept rotating students at this time.


id: cord-343704-td1aheay
author: Rosman, Ilana S.
title: Approaching the dermatology residency application process during a pandemic
date: 2020-07-21
extension: .txt
mime: text/plain
words: 447
sentence: 14
flesch: 21
cache: cache/cord-343704-td1aheay.txt
txt: txt/cord-343704-td1aheay.txt
summary:
  54 • Away rotations: We recommend dermatology programs reserve away rotation 55 opportunities for students without home-institution dermatology options and 56 encourage such students to seek rotations with the closest dermatology practice or 57 program. We propose the above suggestions be 77 adopted broadly to alleviate medical student concerns, address potential inequities in applicant 78 opportunities, and implement socially responsible measures that will position us well for future 79 challenges.


id: cord-322798-5r3kf9wa
author: Freeman, Esther E.
date: 2020-04-09
extension: .txt
mime: text/plain
words: 675
sentence: 28
flesch: 45
cache: cache/cord-322798-5r3kf9wa.txt
txt: txt/cord-322798-5r3kf9wa.txt
title:
  Creating Dermatology Guidelines for Covid-19: The Pitfalls of Applying Evidence Based Medicine to an Emerging Infectious Disease

summary:
  Issues include how to grade evidence from gray literature, risks and benefits of use of anecdotal experiences and indirect evidence, and harmonizing guidance simultaneously produced by other organizations. While we commend the authors for compiling this data, there are several issues with indirect evidence: i) these trials compared biologics to placebo, ii) they were not powered for the outcome of URI, and iii) the similarity of Covid-19 to URI is unknown.


id: cord-303800-h3lvbldz
author: Schultz, Brittney
title: Reply to “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
date: 2020-09-04
extension: .txt
mime: text/plain
words: 484
sentence: 18
flesch: 37
cache: cache/cord-303800-h3lvbldz.txt
txt: txt/cord-303800-h3lvbldz.txt
summary:
  We would also 45 consider rituximab for younger patients without comorbidities and with less severe disease. Rheumatologic dosing of rituximab, rather than 74 hematologic, can be considered to decrease healthcare exposures, and we would recommend 75 against maintenance dosing in stable patients where the risk of disease flare is deemed low.


id: cord-329353-0pwgzeec
author: Wambier, Carlos Gustavo
date: 2020-09-11
extension: .txt
mime: text/plain
words: 705
sentence: 29
flesch: 43
cache: cache/cord-329353-0pwgzeec.txt
txt: txt/cord-329353-0pwgzeec.txt
title:
  Male balding as a major risk factor for severe COVID-19: a possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals

summary:
  It is noteworthy that severe baldness was reported to be a better 43 predictor of test positivity than obesity, as there are many reports linking obesity to COVID-19 44 disease severity. Severe baldness, 52 the Gabrin sign (NHS=3-7), has been associated with both increased ICU admissions and 53 increased death rates.


id: cord-268072-pt2u6608
author: Oranges, Teresa
title: Reply to: “Skin damage among health care workers managing coronavirus disease-2019”
date: 2020-04-10
extension: .txt
mime: text/plain
words: 609
sentence: 24
flesch: 48
cache: cache/cord-268072-pt2u6608.txt
txt: txt/cord-268072-pt2u6608.txt
summary:
  key: cord-268072-pt2u6608 authors: Oranges, Teresa; Janowska, Agata; Dini, Valentina title: Reply to: “Skin damage among health care workers managing coronavirus disease-2019” date: 2020-04-10 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.04.003 sha: doc_id: 268072 cord_uid: pt2u6608 nan Reply to: ''Skin damage among health care workers managing coronavirus disease-2019'' To the Editor: We read with interest the article ''Skin damage among health care workers managing coronavirus disease-2019'' written by Lan et al. 1 Lan et al 1 reported that the health care workers who wore medical devices for more than 6 hours showed higher risks of skin damage, with desquamation in more than 60% of cases, and other signs, such as erythema, maceration, and ulcers, in a smaller percentage of cases.


id: cord-322435-c88tkbnz
author: Rekhtman, Sergey
date: 2020-10-24
extension: .txt
mime: text/plain
words: 1491
sentence: 65
flesch: 45
cache: cache/cord-322435-c88tkbnz.txt
txt: txt/cord-322435-c88tkbnz.txt
title:
  Mucocutaneous Disease and Related Clinical Characteristics in Hospitalized Children and Adolescents with COVID-19 and MIS-C

summary:
  Results In COVID-19 patients, 4/12 (33%) had rash and/or mucositis, including erythema, morbilliform pattern, and lip mucositis. COVID-19 patients with rash had less frequent respiratory symptoms, PICU admission, and invasive ventilation, as well as shorter stay (vs COVID-19 without rash).


